(19)
(11) EP 4 573 095 A1

(12)

(43) Date of publication:
25.06.2025 Bulletin 2025/26

(21) Application number: 23769053.2

(22) Date of filing: 16.08.2023
(51) International Patent Classification (IPC): 
C07D 471/22(2006.01)
A61P 35/00(2006.01)
C07D 498/22(2006.01)
A61K 31/519(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/22; C07D 498/22; A61P 35/00
(86) International application number:
PCT/US2023/072332
(87) International publication number:
WO 2024/040131 (22.02.2024 Gazette 2024/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.08.2022 US 202263398737 P
21.11.2022 US 202263426885 P
31.03.2023 US 202363456316 P
13.07.2023 US 202363526503 P

(71) Applicant: Treeline Biosciences, Inc.
Watertown, Massachusetts 02472 (US)

(72) Inventors:
  • LAJINESS, James Paul
    San Diego, California 92121 (US)
  • GIANATASSIO, Ryan L.
    San Diego, California 92121 (US)
  • MARRONE, Tami J.
    San Diego, California 92121 (US)
  • MCCLYMONT, Kyle Stephen
    San Diego, California 92121 (US)
  • VALIERE, Andrew
    San Diego, California 92121 (US)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) PYRIDOPYRIMIDINE KRAS INHIBITORS